Skip to content

Clinical trials

Phase 2 Squamous Cell Carcinoma of Head and Neck trials in the Netherlands

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Squamous Cell Carcinoma of Head and Neck Phase: Phase 2 Country / region: Netherlands Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20081
20121
20151
20181
20192
20214
20222
20231
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Active, not recruiting2
Terminated2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
ALX Oncology Inc.2
Erasmus Medical Center2
Kura Oncology, Inc.2
Radboud University Medical Center2
European Organisation for Research and Treatment of Cancer - EORTC1
ISA Pharmaceuticals1
Incyte Biosciences International Sàrl1
Merck Sharp & Dohme LLC1
PCI Biotech AS1
Sanofi1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Squamous Cell Carcinoma of Head and Neck15
Head and Neck Neoplasms9
Neoplasms2
Carcinoma, Hepatocellular1
Carcinoma, Squamous Cell1
Cholangiocarcinoma1
Endometrial Neoplasms1
Esophageal Neoplasms1
Gallbladder Neoplasms1
Mouth Neoplasms1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.